In over 50% of tumor evaluations, the patients had CA19-9 and CEA levels higher than standard values; CA19-9 had increased since inclusion in 25.3% (n = 86, 15 missing) and CEA in 39.4% (n = 138, 5 missing) of tumor evaluations. Here, CEACAM5 is linked to neoplasm.